India's Pharmaceutical Exports

Country Profile

Djibouti

Djibouti is an emerging destination for Indian pharmaceutical exports — $43.1M in FY 2025–26, with 39.9× growth over the past decade. Medicines accounts for 87% of shipments, with vaccines contributing $259K. The compound annual growth rate since FY2015 stands at 39.8%.

🇩🇯 $43.1M · 39.9× growth since FY2015 · 39.8% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$43.1M
Exports FY2025–26 DGCIS
39.9×
Growth FY2015→2026
39.8%
CAGR FY2015→2026
87%
Medicines Share
5
Product Categories Supplied
Djibouti is an emerging destination for Indian pharmaceutical exports — $43.1M in FY 2025–26, with 39.9× growth over the past decade. Medicines accounts for 87% of shipments, with vaccines contributing $259K. The compound annual growth rate since FY2015 stands at 39.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $37.3M (86.5%) Medicine Ingredients $3.97M (9.2%) Surgical & Hospital Supplies $1.49M (3.5%) Vaccines $259K (0.6%) Traditional & Herbal $92K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Djibouti in the RBI overseas direct investment dataset (2011–2026).